Scientists have developed two experimental vaccines targeting the deadly Bundibugyo virus, which has caused thousands of fatalities in the Democratic Republic of Congo. The breakthrough comes as health officials continue to monitor outbreaks of the virus, which belongs to the same family as Ebola but has received far less attention. Early research suggests the vaccines could provide a critical tool in combating future epidemics, though further testing is required before widespread use. With no approved treatments currently available, these developments mark a potential turning point in the fight against a lethal but often overlooked pathogen.
Two new vaccines were designed for the Bundibugyo virus that has killed more than 5,300 in the DR Congo.
